Cancer epidemiology and trends in Sistan and Baluchestan province, Iran
Authors
Abstract:
Background: is the third cause of death. The present study aimed at providing the incidence rates (crude and agestandardized)of different types of cancers in Sistan and Baluchestan province (Southeastern of Iran).Cancer is the second leading cause of death in developing countries. In Iran, cancerMethodsRegistry Center of Health Heputy for Sistan and Baluchestan province. Common cancers weredefined based on the number of cases and standardized incidence rates. To compute the annual percentagechange (APC), joinpoint 4.1.1.1 software was applied.: Data were collected retrospectively reviewing all new cancer patients registered in CancerResults46.82% occurred in females and 53.18% in males. The most frequent cancer in women was breastcancer followed by esophagus, skin, colorectal and leukemia. The 5 most frequent cancers in menwere stomach, skin, leukemia, esophagus and bladder. Joinpoint analyze showed a significant increasingtrend for adjusted standard incidence rate (ASIR) for both sexes (p<0.05).: A total of 3535 cases of cancers registered during 2004-2009 were identified. Of these,Conclusionother provinces in Iran, cancer incidence in Sistan and Baluchistan is less common but trends of cancersare increasing in Sistan and Baluchestan Province. It is necessary to have a comprehensivehealth policy for prevention and control of this problem.: According to The results of the present study and comparison to previous studies for
similar resources
cancer epidemiology and trends in sistan and baluchestan province, iran
background: is the third cause of death. the present study aimed at providing the incidence rates (crude and agestandardized)of different types of cancers in sistan and baluchestan province (southeastern of iran).cancer is the second leading cause of death in developing countries. in iran, cancermethodsregistry center of health heputy for sistan and baluchestan province. common cancers weredefi...
full textEpidemiology And Trend Of Skin Cancer Incidence In Sistan And Baluchestan Province, Iran
Skin cancer is one of the most common cancers worldwide. More specifically, it is the leading cancer for Iranian men and the second most common cancer in Iranian women. Being aware of the epidemiological situation and the trend of the disease is necessary for further studies and better planning for prevention. This study aims to investigate the epidemiology, and trend of skin cancer incidence i...
full textEpidemiology and trends in mortality from liver cancer in Iran
Liver cancer is the sixth most common cancer worldwide and the third leading cause of death from cancer. Liver cancer is more prevalent in countries in East Asia, Southeast Asia and the western Central Africa.1 Liver cancer rates in North America and Western Europe, less than 10 cases per hundred thousand people in Asia and Africa between 50-150 cases per hundred thousand people.2 The inc...
full textThe marine algae of the Sistan and Baluchestan Province, Iran
The identification of marine algae in the Sistan and Baluchestan Province were performed from December 1998 to November 1999 at the coastal area of Gwatr (25 10´ N; 61 30´ E) and Mydani (25 24´ N; 59 5´ E). Data on vegetation were gathered in subtidal and intertidal zones by seasonal and monthly sampling, respectively. Samples were transferred to the laboratory and fixed...
full textThe marine algae of the Sistan and Baluchestan Province, Iran
The identification of marine algae in the Sistan and Baluchestan Province were performed from December 1998 to November 1999 at the coastal area of Gwatr (25 10´ N; 61 30´ E) and Mydani (25 24´ N; 59 5´ E). Data on vegetation were gathered in subtidal and intertidal zones by seasonal and monthly sampling, respectively. Samples were transferred to the laboratory and fixed in 4% formalin. Accordi...
full textMy Resources
Journal title
volume 29 issue 1
pages 752- 759
publication date 2015-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023